vs
Digimarc CORP（DMRC）与礼来（RNA）财务数据对比。点击上方公司名可切换其他公司
礼来的季度营收约是Digimarc CORP的1.4倍（$12.5M vs $8.9M），Digimarc CORP净利率更高（-47.2% vs -1398.3%，领先1351.1%），礼来同比增速更快（434.0% vs 2.9%），Digimarc CORP自由现金流更多（$895.0K vs $-156.9M），过去两年礼来的营收复合增速更高（138.5% vs -5.3%）
迪吉马克公司是一家企业软件与服务提供商，其主打产品包含带数字标识符的软件，主要用于解决防伪问题、验证产品真伪、提升回收准确性以及实现供应链可追溯，产品可广泛应用于服装、快消品、美妆健康、汽车等多个行业领域。
礼来是总部位于美国印第安纳州印第安纳波利斯的跨国制药企业，在18个国家设有办事处，产品销往全球约125个国家。公司由美国内战时期联邦军退伍军人、药剂师伊莱·礼来于1876年创立，品牌名即取自创始人姓名。
DMRC vs RNA — 直观对比
营收规模更大
RNA
是对方的1.4倍
$8.9M
营收增速更快
RNA
高出431.1%
2.9%
净利率更高
DMRC
高出1351.1%
-1398.3%
自由现金流更多
DMRC
多$157.8M
$-156.9M
两年增速更快
RNA
近两年复合增速
-5.3%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $8.9M | $12.5M |
| 净利润 | $-4.2M | $-174.4M |
| 毛利率 | 63.5% | — |
| 营业利润率 | -48.2% | -1513.5% |
| 净利率 | -47.2% | -1398.3% |
| 营收同比 | 2.9% | 434.0% |
| 净利润同比 | 51.4% | -117.0% |
| 每股收益（稀释后） | $-0.18 | $-1.27 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DMRCRNA
| Q4 25 | $8.9M | — | ||
| Q3 25 | $7.6M | $12.5M | ||
| Q2 25 | $8.0M | $3.8M | ||
| Q1 25 | $9.4M | $1.6M | ||
| Q4 24 | $8.7M | $3.0M | ||
| Q3 24 | $9.4M | $2.3M | ||
| Q2 24 | $10.4M | $2.0M | ||
| Q1 24 | $9.9M | $3.5M |
净利润DMRCRNA
| Q4 25 | $-4.2M | — | ||
| Q3 25 | $-8.2M | $-174.4M | ||
| Q2 25 | $-8.2M | $-157.3M | ||
| Q1 25 | $-11.7M | $-115.8M | ||
| Q4 24 | $-8.6M | $-102.3M | ||
| Q3 24 | $-10.8M | $-80.4M | ||
| Q2 24 | $-9.3M | $-70.8M | ||
| Q1 24 | $-10.3M | $-68.9M |
毛利率DMRCRNA
| Q4 25 | 63.5% | — | ||
| Q3 25 | 58.3% | — | ||
| Q2 25 | 58.8% | — | ||
| Q1 25 | 65.0% | — | ||
| Q4 24 | 60.8% | — | ||
| Q3 24 | 62.4% | — | ||
| Q2 24 | 66.1% | — | ||
| Q1 24 | 62.5% | — |
营业利润率DMRCRNA
| Q4 25 | -48.2% | — | ||
| Q3 25 | -109.7% | -1513.5% | ||
| Q2 25 | -105.2% | -4448.7% | ||
| Q1 25 | -128.9% | -8360.9% | ||
| Q4 24 | -105.1% | -4069.6% | ||
| Q3 24 | -120.4% | -4200.9% | ||
| Q2 24 | -96.2% | -4040.4% | ||
| Q1 24 | -109.2% | -2178.6% |
净利率DMRCRNA
| Q4 25 | -47.2% | — | ||
| Q3 25 | -106.9% | -1398.3% | ||
| Q2 25 | -102.6% | -4089.3% | ||
| Q1 25 | -125.2% | -7360.0% | ||
| Q4 24 | -99.9% | -3439.5% | ||
| Q3 24 | -113.9% | -3441.7% | ||
| Q2 24 | -89.3% | -3461.8% | ||
| Q1 24 | -104.0% | -1943.4% |
每股收益（稀释后）DMRCRNA
| Q4 25 | $-0.18 | — | ||
| Q3 25 | $-0.38 | $-1.27 | ||
| Q2 25 | $-0.38 | $-1.21 | ||
| Q1 25 | $-0.55 | $-0.90 | ||
| Q4 24 | $-0.40 | $-0.80 | ||
| Q3 24 | $-0.50 | $-0.65 | ||
| Q2 24 | $-0.43 | $-0.65 | ||
| Q1 24 | $-0.50 | $-0.79 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $12.9M | $350.2M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $40.2M | $1.9B |
| 总资产 | $53.0M | $2.1B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资DMRCRNA
| Q4 25 | $12.9M | — | ||
| Q3 25 | $12.6M | $350.2M | ||
| Q2 25 | $16.1M | $243.9M | ||
| Q1 25 | $21.6M | $254.2M | ||
| Q4 24 | $28.7M | $219.9M | ||
| Q3 24 | $33.7M | $370.2M | ||
| Q2 24 | $41.5M | $575.8M | ||
| Q1 24 | $48.9M | $471.4M |
股东权益DMRCRNA
| Q4 25 | $40.2M | — | ||
| Q3 25 | $41.4M | $1.9B | ||
| Q2 25 | $46.5M | $1.2B | ||
| Q1 25 | $50.0M | $1.3B | ||
| Q4 24 | $61.4M | $1.4B | ||
| Q3 24 | $70.2M | $1.5B | ||
| Q2 24 | $77.2M | $1.2B | ||
| Q1 24 | $84.5M | $830.9M |
总资产DMRCRNA
| Q4 25 | $53.0M | — | ||
| Q3 25 | $55.4M | $2.1B | ||
| Q2 25 | $60.7M | $1.4B | ||
| Q1 25 | $66.5M | $1.5B | ||
| Q4 24 | $75.8M | $1.6B | ||
| Q3 24 | $85.0M | $1.6B | ||
| Q2 24 | $93.4M | $1.3B | ||
| Q1 24 | $99.7M | $951.5M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $991.0K | $-156.2M |
| 自由现金流经营现金流 - 资本支出 | $895.0K | $-156.9M |
| 自由现金流率自由现金流/营收 | 10.0% | -1257.6% |
| 资本支出强度资本支出/营收 | 1.1% | 5.7% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-12.3M | $-592.3M |
8季度趋势，按日历期对齐
经营现金流DMRCRNA
| Q4 25 | $991.0K | — | ||
| Q3 25 | $-2.6M | $-156.2M | ||
| Q2 25 | $-4.7M | $-199.7M | ||
| Q1 25 | $-5.5M | $-124.8M | ||
| Q4 24 | $-4.2M | $-99.9M | ||
| Q3 24 | $-7.1M | $-65.6M | ||
| Q2 24 | $-6.8M | $-65.0M | ||
| Q1 24 | $-8.4M | $-70.4M |
自由现金流DMRCRNA
| Q4 25 | $895.0K | — | ||
| Q3 25 | $-2.8M | $-156.9M | ||
| Q2 25 | $-4.9M | $-203.0M | ||
| Q1 25 | $-5.5M | $-128.6M | ||
| Q4 24 | $-4.2M | $-103.8M | ||
| Q3 24 | $-7.2M | $-67.3M | ||
| Q2 24 | $-6.9M | $-65.5M | ||
| Q1 24 | $-8.5M | $-71.3M |
自由现金流率DMRCRNA
| Q4 25 | 10.0% | — | ||
| Q3 25 | -36.9% | -1257.6% | ||
| Q2 25 | -61.0% | -5277.1% | ||
| Q1 25 | -59.1% | -8174.3% | ||
| Q4 24 | -49.1% | -3491.0% | ||
| Q3 24 | -75.7% | -2881.8% | ||
| Q2 24 | -66.1% | -3204.6% | ||
| Q1 24 | -85.8% | -2012.3% |
资本支出强度DMRCRNA
| Q4 25 | 1.1% | — | ||
| Q3 25 | 2.9% | 5.7% | ||
| Q2 25 | 2.5% | 86.9% | ||
| Q1 25 | 0.6% | 238.6% | ||
| Q4 24 | 0.2% | 131.7% | ||
| Q3 24 | 0.7% | 72.9% | ||
| Q2 24 | 0.3% | 26.0% | ||
| Q1 24 | 1.1% | 25.8% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DMRC
| Subscription | $5.3M | 60% |
| The Government | $3.6M | 41% |
RNA
暂无分部数据
